SEC 13F Intelligence

Jabodon Pt Co / CYTK

Jabodon Pt Co’s Cytokinetics Inc Position

Does Jabodon Pt Co own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 65.5K shares worth $2M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2022
Shares
65.5K
% of Portfolio
+1.09%
Quarters Held
2
position exited

Position History CYTK

Reported value by quarter
Q4 ’21: $3MQ4 ’21Q1 ’22: $2MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202265.5K$2M+1.09%
Q4 202168.3K$3M+1.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jabodon Pt Co’s full portfolio or all institutional holders of CYTK.